尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the detailed record of transactions filed by Hite Christopher, 董事. Insider active across 2 companies, notably Acceleron Pharma INC. In total, 12 disclosures have been published. Breakdown: 0 buy · 3 sells. Total volume traded: €5.2m. Activity tracked since 13 May 2024. The latest transaction was disclosed on 18 August 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 条申报中的 12 条
Hite Christopher is Administrateur and is reported in 10 filings in total. The recent filings sampled run from 2021-11-22 to 2026-08-07, concern Royalty Pharma plc, and the modal transaction nature is Attribution. In these sampled recent filings, the reported buy and sell amounts are 0 and 0.